Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published.
Background: Mild cognitive impairment (MCI) has been considered a transitional state between normal aging and dementia, characterised by memory impairment but normal general cognitive functioning.
Data Synthesis: Reports of statin-associated cognitive impairment were found primarily in observational studies (eg, case reports/series). One randomized controlled trial demonstrated that ...
Eli Lilly also gained FDA approval for its treatment, Kisunla (donanemab), for use in patients with mild cognitive impairment or the mild dementia stage of Alzheimer’s. The two treatments are ...
Annals of Family Medicine is proud to announce the early online publication of four impactful articles focusing on artificial intelligence (AI) and its role in primary care. These articles, now ...
In January 2023, lecanemab received accelerated approval for the management of mild cognitive impairment associated ... in prescribing [a] drug with uncertain benefits for patients often desperate ...
China has announced that vice president Han Zheng will attend the inauguration of US President-elect Donald Trump as President Xi Jinping's special representative. This move highlights China's ...
Jan. 8, 2025 — Older people wait an average of just over a month to see a neurologist for specialty care after being referred by their primary care physician or another physician, according to a ...